Arbutus Biopharma Corp (ABUS) › EPS (Diluted)Arbutus Biopharma Corp (ABUS) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2011: $-0.892012: $2.072013: $-0.922014: $-1.802015: $-1.382016: $-7.242017: $-1.562018: $-1.212020: $-1.002021: $-0.832022: $-0.462023: $-0.442024: $-0.382025: $-0.17$-0.172011EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-0.17+55.3%2024$-0.38+13.6%2023$-0.44+4.3%2022$-0.46+44.6%2021$-0.83+17.0%2020$-1.00—2018$-1.21+22.4%2017$-1.56+78.5%2016$-7.24-424.6%2015$-1.38+23.3%2014$-1.80-95.7%2013$-0.92-144.4%2012$2.07+332.6%2011$-0.89—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share